Your browser doesn't support javascript.
loading
Pretreatment body mass index affects achievement of target blood pressure with sodium-glucose cotransporter 2 inhibitors in patients with type 2 diabetes mellitus and chronic kidney disease.
Tsukamoto, Shunichiro; Kobayashi, Kazuo; Toyoda, Masao; Hatori, Nobuo; Kanaoka, Tomohiko; Wakui, Hiromichi; Sakai, Hiroyuki; Furuki, Takayuki; Chin, Keiichi; Ito, Shun; Suzuki, Daisuke; Umezono, Tomoya; Aoyama, Togo; Nakajima, Shinichi; Hishiki, Toshimasa; Hatori, Yutaka; Hayashi, Masahiro; Shimura, Hidetoshi; Minagawa, Fuyuki; Mokubo, Atsuko; Takihata, Masahiro; Sato, Kazuyoshi; Miyakawa, Masaaki; Terauchi, Yasuo; Tamura, Kouichi; Kanamori, Akira.
  • Tsukamoto S; Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Kobayashi K; Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan. k-taishi@xc4.so-net.ne.jp.
  • Toyoda M; Committee of Hypertension and Kidney disease, Kanagawa Physicians Association, Yokohama, Japan. k-taishi@xc4.so-net.ne.jp.
  • Hatori N; Division of Nephrology, Endocrinology and Metabolism, Department of internal medicine, Tokai University School of Medicine, lsehara, Japan.
  • Kanaoka T; Committee of Hypertension and Kidney disease, Kanagawa Physicians Association, Yokohama, Japan.
  • Wakui H; Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Sakai H; Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Furuki T; Committee of Hypertension and Kidney disease, Kanagawa Physicians Association, Yokohama, Japan.
  • Chin K; Committee of Hypertension and Kidney disease, Kanagawa Physicians Association, Yokohama, Japan.
  • Ito S; Committee of Hypertension and Kidney disease, Kanagawa Physicians Association, Yokohama, Japan.
  • Suzuki D; Committee of Hypertension and Kidney disease, Kanagawa Physicians Association, Yokohama, Japan.
  • Umezono T; Committee of Hypertension and Kidney disease, Kanagawa Physicians Association, Yokohama, Japan.
  • Aoyama T; Committee of Hypertension and Kidney disease, Kanagawa Physicians Association, Yokohama, Japan.
  • Nakajima S; Division of Nephrology, Department of internal medicine, Kitasato University School of Medicine, Sagamihara, Japan.
  • Hishiki T; Committee of Hypertension and Kidney disease, Kanagawa Physicians Association, Yokohama, Japan.
  • Hatori Y; Committee of Hypertension and Kidney disease, Kanagawa Physicians Association, Yokohama, Japan.
  • Hayashi M; Committee of Hypertension and Kidney disease, Kanagawa Physicians Association, Yokohama, Japan.
  • Shimura H; Committee of Hypertension and Kidney disease, Kanagawa Physicians Association, Yokohama, Japan.
  • Minagawa F; Committee of Hypertension and Kidney disease, Kanagawa Physicians Association, Yokohama, Japan.
  • Mokubo A; Committee of Hypertension and Kidney disease, Kanagawa Physicians Association, Yokohama, Japan.
  • Takihata M; Committee of Hypertension and Kidney disease, Kanagawa Physicians Association, Yokohama, Japan.
  • Sato K; Committee of Hypertension and Kidney disease, Kanagawa Physicians Association, Yokohama, Japan.
  • Miyakawa M; Committee of Hypertension and Kidney disease, Kanagawa Physicians Association, Yokohama, Japan.
  • Terauchi Y; Committee of Hypertension and Kidney disease, Kanagawa Physicians Association, Yokohama, Japan.
  • Tamura K; Department of Endocrinology and Metabolism, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
  • Kanamori A; Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan. tamukou@yokohama-cu.ac.jp.
Hypertens Res ; 47(3): 628-638, 2024 Mar.
Article en En | MEDLINE | ID: mdl-37848562
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Insuficiencia Renal Crónica / Inhibidores del Cotransportador de Sodio-Glucosa 2 Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 2 / Insuficiencia Renal Crónica / Inhibidores del Cotransportador de Sodio-Glucosa 2 Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article